These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 34368156)

  • 21. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy.
    He Y; de Araújo Júnior RF; Cruz LJ; Eich C
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
    Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
    ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting macrophages: a novel treatment strategy in solid tumors.
    Liu M; Liu L; Song Y; Li W; Xu L
    J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
    Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
    Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-Activated Protein Kinase Pathway: A Critical Regulator in Tumor-associated Macrophage Polarization.
    Neamatallah T
    J Microsc Ultrastruct; 2019; 7(2):53-56. PubMed ID: 31293885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression.
    Li H; Yang C; Wei Y; Li X; Jiang W; Xu Y; Li L; Guo R; Chen D; Gao P; Zhang H; Qin H; Zhang Z; Liu X; Yan D
    Theranostics; 2023; 13(11):3794-3813. PubMed ID: 37441589
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
    Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
    Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
    Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
    Front Immunol; 2022; 13():964898. PubMed ID: 35967394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression.
    Yan C; Yang Z; Chen P; Yeh Y; Sun C; Xie T; Huang W; Zhang X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):105. PubMed ID: 38576043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth.
    Li Y; Wang W; Hou X; Huang W; Zhang P; He Y; Wang B; Duan Q; Mao F; Guo D
    Cell Death Dis; 2023 Jan; 14(1):28. PubMed ID: 36639372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophages in glioma: friend or foe?
    Kennedy BC; Showers CR; Anderson DE; Anderson L; Canoll P; Bruce JN; Anderson RC
    J Oncol; 2013; 2013():486912. PubMed ID: 23737783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.
    Tan Y; Wang M; Zhang Y; Ge S; Zhong F; Xia G; Sun C
    Front Oncol; 2021; 11():693517. PubMed ID: 34178692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment.
    Yang W; Yang S; Zhang F; Cheng F; Wang X; Rao J
    Ann Transl Med; 2020 Mar; 8(6):399. PubMed ID: 32355843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Jul; ():. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression.
    Kuznetsova AB; Kolesova EP; Parodi A; Zamyatnin AA; Egorova VS
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated macrophages: an effective player of the tumor microenvironment.
    Basak U; Sarkar T; Mukherjee S; Chakraborty S; Dutta A; Dutta S; Nayak D; Kaushik S; Das T; Sa G
    Front Immunol; 2023; 14():1295257. PubMed ID: 38035101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.